本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

13.07
-0.5400-3.97%
盤前13.100.0300+0.23%04:58 EDT
成交量:565.48萬
成交額:7,404.19萬
市值:12.85億
市盈率:-2.24
高:13.59
開:13.56
低:12.88
收:13.61
52周最高:39.89
52周最低:12.88
股本:9,831.72萬
流通股本:8,071.56萬
量比:1.21
換手率:7.01%
股息:- -
股息率:- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
淨資產收益率:-608.47%
總資產收益率:-24.22%
市淨率:-4.42
市盈率(LYR):-2.24

資料載入中...

2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/23

重要事件披露

Form 8-K - Current report
2023/10/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/19

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/10/16

重要事件披露

Form 8-K - Current report
2023/09/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

重要事件披露

Form 8-K - Current report
2023/09/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/07/12

重要事件披露

Form 8-K - Current report